PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study
Ioannis Tarnanas (@ITarnanas) | Twitter
Ioannis Tarnanas | Nature Portfolio Health Community
Stream Ioannis Tarnanas: Atlantic Equity for Equity in Brain Health by Atlantic Fellows | Listen online for free on SoundCloud
Loop | Ioannis Tarnanas
Altoida Receives Investment from Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator to Advance Precision Neurology
Interviews - Trinity Development & Alumni - Trinity College Dublin
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Ioannis Tarnanas's Page – iACToR
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas, Expert Evaluator, EIT Health Alumni Network
Ioannis Tarnanas - Worldwebforum
EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer's and detect stroke risk - EIT Health
Ioannis Tarnanas on Twitter: "John Baldoni from GSK describing their bold practice of publicing internal trial's datasets at the public domain. An admirable approach and a practice to be replicated! #PrecisionHealth… https://t.co/luozl6YMIO"
Ioannis Tarnanas - Worldwebforum
Impact Hub Zürich - Ioannis Tarnanas is Impact Hub Fellow on Healthy Living. frederike asael photography | Facebook
Alzheimer europe virtual museum
Ioannis Tarnanas (@ITarnanas) | Twitter
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Interview with venture case winner Alterniity: We didn't fly too high or too low”
Ioannis Tarnanas presentations | SlideShare
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
